Discovery and Synthesis of a Novel Series of Liver X Receptor Antagonists
Fourteen novel compounds were prepared and their antagonistic activities against liver X receptors (LXR) α/β were tested in vitro. Compound 26 had an IC50 value of 6.4 µM against LXRα and an IC50 value of 5.6 µM against LXRβ. Docking studies and the results of structure–activity relationships support the further development of this chemical series as LXRα/β antagonists.
研究领域:
药理学
·
分子生物学
✓ 已验证
DOI
高影响因子
危险品化学品经营许可证(带存储)